A randomized study to assess the effect on response rate of MabThera (rituximab) added to a standard chemotherapy, Bendamustine or Chlorambucil, in patients with Chronic Lymphocytic Leukemia.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Rituximab (Primary) ; Bendamustine; Chlorambucil
- Indications Chronic lymphocytic leukaemia
- Focus Registrational; Therapeutic Use
- Acronyms MaBLe; RiBECCA
- Sponsors Roche
- 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Jan 2014 Planned End Date changed from 1 May 2014 to 1 Apr 2014 as per ClinicalTrials.gov record.
- 07 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History